FNA (FNA)
Paragon 28, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
Paragon 28, Inc. is a medical device company specializing in the development, manufacturing, and global distribution of advanced surgical systems tailored for foot and ankle procedures.
Its comprehensive product portfolio encompasses a wide array of solutions: Plating Systems: This includes the Gorilla plating series, offering specific solutions for Lisfranc injuries, Lapidus procedures, lateral column corrections, calcaneus slides, and naviculocuneiform (NC) fusions. Complementary products like Baby Gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates, as well as Silverback plating systems, are also available. Precision Guidance Technology: The company provides sophisticated guidance systems to enhance accuracy in various operations, such as fusion procedures for bunion deformities, first tarsometatarsal arthrodesis, metatarsal osteotomy for bunion correction, medial column beaming for Charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. Screw Systems: Paragon 28 offers robust screw systems, including the Monster, Mini Monster, and Joust beaming lines, which are critical for applications like bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, and fracture repair. Joint Replacement Solutions: Their offerings extend to total ankle replacement with the APEX 3D systems, alongside total talus spacers designed to replace the talus bone that links the leg and foot. Bunion/Hallux Valgus Correction Systems: Specifically for bunion management, the company provides nail systems such as the Phantom intramedullary nail systems, targeting severe hallux valgus cases. Orthobiologics: A substantial part of their product line comprises various orthobiologics, including bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix. They also feature PRESERVE bone graft systems for homologous applications. Ancillary Products: The company further supplies soft tissue fixation systems, titanium sprayed polyetheretherketone (PEEK) implants, nitinol staple systems, stabilization solutions, and specialized curved instruments. Paragon 28 distributes its products to hospitals and ambulatory surgery centers through an established network of both direct sales representatives and stocking distributors. Founded in 2010, the company maintains its corporate headquarters in Englewood, Colorado.
Leadership
Albert DaCosta
Co-Founder, Chairman, President & Chief Executive Officer
Drew Hill
Executive Vice President of Research and Development
Erik Mickelson
Chief Accounting Officer and Controller
Kristina Wright
Interim Chief Financial Officer, Director
Employees
525
Country
US
Sector
Healthcare
Website
paragon28.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| See Remarks | Withholding/Transfer | 203.1K | -- | Apr 21, 2025 | |
| Director | Withholding/Transfer | 42.1K | -- | Apr 21, 2025 | |
| Director | Withholding/Transfer | 45.0K | -- | Apr 21, 2025 | |
| Director | Withholding/Transfer | 40.2K | -- | Apr 21, 2025 | |
| Director | Withholding/Transfer | 47.3K | -- | Apr 21, 2025 | |
| Chief Commercial Officer | Withholding/Transfer | 575.3K | -- | Apr 21, 2025 |
| Name | Shares | % | Source |
|---|---|---|---|
DaCosta Albert See Remarks, Director, 10% Owner | 1.3M | -- | FORM 4 |
Jarboe Matthew Chief Commercial Officer | 575.3K | -- | FORM 4 |
Chahine Chadi See Remarks | 520.7K | -- | FORM 4 |
McCormack Robert S See Remarks | 203.1K | -- | FORM 4 |
Hill Andrew James EVP of Research & Development | 126.4K | -- | FORM 4 |
Demski David M Director | 74.3K | -- | FORM 4 |
WRIGHT KRISTINA Director | 32.1K | -- | FORM 4 |
Lindbrook Capital, LLC | 212 | -- | 13F |
Insiders
- McCormack Robert SSee Remarks
- Scanlon MeghanDirector
- SCHNETTLER THOMAS PDirector
- Oesterle Stephen N.Director
- JOHNSON B KRISTINEDirector
- Jarboe MatthewChief Commercial Officer
- Hill Andrew JamesEVP of Research & Development
- Blackford Quentin S.Director
- WRIGHT KRISTINADirector
- Chahine ChadiSee Remarks
Top institutional holders
30d Avg
--
60d Avg
--
90d Avg
--